| Home > In process > Perivascular Spaces Are Associated With CSF Aβ in Cerebral Amyloid Angiopathy But Not in Deep Perforator Arteriopathy. |
| Journal Article | DZNE-2026-00444 |
; ; ; ; ; ; ; ; ; ; ;
2026
Association
New York, NY
This record in other databases:
Please use a persistent id in citations: doi:10.1161/STROKEAHA.125.053794
Abstract: Centrum semiovale perivascular spaces (CSO PVS) are common to different cerebral small vessel disease (CSVD) subtypes, yet their enlargement to the point of visibility on magnetic resonance imaging is thought to occur through distinct mechanisms. In cerebral amyloid angiopathy (CAA), CSO PVS are thought to reflect impaired perivascular Aβ (amyloid-β) drainage, whereas in deep perforator arteriopathy (DPA) they may result from microangiopathy-related arterial stiffening and altered fluid dynamics. The extent to which this can be confirmed in vivo remains unclear.We retrospectively analyzed 186 patients with CSVD and cerebrospinal fluid (CSF) Aβ biomarkers (n=111 probable CAA, n=75 DPA). CSO PVS were counted on axial T2-weighted images. Associations between CSO PVS and CSF biomarkers were assessed via Pearson correlation and multivariable linear regression, including an interaction term between CSF Aβ and CSVD subtype, adjusted for demographics and neuroimaging markers of CSVD.Patients with higher CSO PVS counts were generally younger, had lower white matter hyperintensity burden, higher basal ganglia PVS counts, and were more frequently affected by cortical superficial siderosis. CSO PVS counts were similar in patients with CAA and DPA. The association between CSF Aβ42/40 ratio and CSO PVS burden was observed in patients with CAA, but not in those with DPA (interaction term between CSF Aβ42/40 ratio and CAA: β=-0.27; P=0.016), independent of demographics and other neuroimaging markers of CSVD. CSF Aβ40 showed no association with CSO PVS counts in any model.Our findings strengthen the pathophysiological link between CSO PVS and Aβ pathology in CAA but not in DPA. These results extend previous histopathologic and neuroimaging work and underscore the need to interpret CSO PVS in the context of underlying CSVD subtype.
Keyword(s): Humans (MeSH) ; Male (MeSH) ; Amyloid beta-Peptides: cerebrospinal fluid (MeSH) ; Female (MeSH) ; Cerebral Amyloid Angiopathy: cerebrospinal fluid (MeSH) ; Cerebral Amyloid Angiopathy: diagnostic imaging (MeSH) ; Cerebral Amyloid Angiopathy: pathology (MeSH) ; Aged (MeSH) ; Glymphatic System: diagnostic imaging (MeSH) ; Glymphatic System: pathology (MeSH) ; Retrospective Studies (MeSH) ; Middle Aged (MeSH) ; Magnetic Resonance Imaging (MeSH) ; Cerebral Small Vessel Diseases: cerebrospinal fluid (MeSH) ; Cerebral Small Vessel Diseases: diagnostic imaging (MeSH) ; Biomarkers: cerebrospinal fluid (MeSH) ; Aged, 80 and over (MeSH) ; cerebral amyloid angiopathy ; cerebrospinal fluid ; magnetic resonance imaging ; neuroimaging ; siderosis
|
The record appears in these collections: |